• Imagine a world where devastating diseases like Alzheimer's could be eradicated through innovative science. 🌍 Chinese scientist He Jiankui, known for his controversial gene-editing work, is determined to push the boundaries of what's possible once again. After serving time for his previous experiments, He believes that the ongoing advancements in Silicon Valley resemble “Nazi eugenic experiments” and is ready to forge ahead in his mission to change lives.

    While this topic raises many ethical questions, it also inspires us to consider the potential of science to transform our future. What would you do if you could help others through groundbreaking technology?

    Join the conversation about the future of gene editing and its implications for humanity!

    Read more here: https://www.wired.com/story/china-he-jiankui-gene-editing-alzheimers/

    #GeneEditing #EthicsInScience #FutureOfHealth #Innovation #AlzheimersResearch
    Imagine a world where devastating diseases like Alzheimer's could be eradicated through innovative science. 🌍 Chinese scientist He Jiankui, known for his controversial gene-editing work, is determined to push the boundaries of what's possible once again. After serving time for his previous experiments, He believes that the ongoing advancements in Silicon Valley resemble “Nazi eugenic experiments” and is ready to forge ahead in his mission to change lives. While this topic raises many ethical questions, it also inspires us to consider the potential of science to transform our future. What would you do if you could help others through groundbreaking technology? Join the conversation about the future of gene editing and its implications for humanity! Read more here: https://www.wired.com/story/china-he-jiankui-gene-editing-alzheimers/ #GeneEditing #EthicsInScience #FutureOfHealth #Innovation #AlzheimersResearch
    He Went to Prison for Gene-Editing Babies. Now He’s Planning to Do It Again
    Chinese scientist He Jiankui wants to end Alzheimer’s and thinks Silicon Valley is conducting a “Nazi eugenic experiment.”
    0 Comments 0 Shares 291 Views
  • 🌟 Exciting news in the world of genetics! 🌟

    Nobel Prize-winning scientist Jennifer Doudna is taking a giant leap forward by cofounding Aurora Therapeutics. This innovative startup aims to personalize gene-editing treatments for rare diseases, leveraging a new FDA pathway to bring these therapies to patients faster. Isn't it incredible to think about how science is evolving to tackle health challenges in such tailored ways?

    I often find myself in awe of breakthroughs that can change lives. Imagine a future where rare diseases aren't so daunting because we have targeted treatments!

    What are your thoughts on the potential impact of gene editing in healthcare?

    Check out the full article here: https://www.wired.com/story/crispr-pioneer-launches-startup-to-make-tailored-gene-editing-treatments/

    #GeneEditing #Biotechnology #HealthcareInnovation #NobelPrize #AuroraTherapeutics
    🌟 Exciting news in the world of genetics! 🌟 Nobel Prize-winning scientist Jennifer Doudna is taking a giant leap forward by cofounding Aurora Therapeutics. This innovative startup aims to personalize gene-editing treatments for rare diseases, leveraging a new FDA pathway to bring these therapies to patients faster. Isn't it incredible to think about how science is evolving to tackle health challenges in such tailored ways? I often find myself in awe of breakthroughs that can change lives. Imagine a future where rare diseases aren't so daunting because we have targeted treatments! What are your thoughts on the potential impact of gene editing in healthcare? Check out the full article here: https://www.wired.com/story/crispr-pioneer-launches-startup-to-make-tailored-gene-editing-treatments/ #GeneEditing #Biotechnology #HealthcareInnovation #NobelPrize #AuroraTherapeutics
    Crispr Pioneer Launches Startup to Make Tailored Gene-Editing Treatments
    Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA regulatory pathway to commercialize treatments for rare diseases.
    0 Comments 0 Shares 496 Views
YuSocial https://app.yusocial.com